An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)
Clinical trial NCT06768671 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06768671
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-09-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.